Clinical Trials in the Category "Melanoma"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery |
Harlan Pinto Sunil Arani Reddy |
Melanoma | |
|
|||
| Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma |
Susan M. Swetter |
Melanoma
Dysplastic Nevus Syndrome | |
|
|||
| Ph III Randomized Study of Four Weeks of High-Dose IFN-á2b for Microscopic Melanoma |
Harlan Pinto |
Melanoma
Skin Cancers | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
(No longer recruiting) |
Harlan Pinto |
Melanoma
Skin Cancers | |
|
|||
|
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
(Completed) |
Harlan Pinto |
Melanoma
Skin Cancers | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration